Edgewise Therapeutics Inc (EWTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.03B
Last updated: Nov 17, 2026 at 4:20 PM ET
Edgewise Therapeutics Inc (EWTX) Stock Chart
Edgewise Therapeutics (EWTX) has a latest price of $42.04 on Nov 17, 2026, 13.8% below its 52-week high of $48.78. Its price rose 84.8% over the past 12 months. The month-end price rose 135.8% over the 5 years through Oct 2026, a compound annual rate of 18.7%.
Price Chart
From Mar 2021 to Oct 2026, its highest month-end close was $41.77 in Aug 2026 and its lowest $5.73 in Sep 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart EWTX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for EWTX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 9.5%, and over 6 months it rose 33.8%. The month-end price rose 507.8% over the 3 years through Oct 2026, a compound annual rate of 82.5%.
| Period | Change |
|---|---|
| 1 month | +10.9% |
| 3 months | -9.5% |
| 6 months | +33.8% |
| 12 months | +84.8% |
| 12 months, with dividends | +84.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +507.8% | +82.5% |
| 5 years | +135.8% | +18.7% |
Price by Year
Its best calendar year was 2024, when the price rose 144.1%, and its weakest was 2022, when it fell 41.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $38.90 | +56.8% |
| 2025 | $24.82 | -7.1% |
| 2024 | $26.70 | +144.1% |
| 2023 | $10.94 | +22.4% |
| 2022 | $8.94 | -41.5% |
Trading Range
The price is 1.8% above its 50-day average of $41.31 and 13.2% above its 200-day average of $37.15.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $42.04 | |
| 52-week high | $48.78 | -13.8% |
| 52-week low | $19.76 | +112.8% |
| 50-day average | $41.31 | +1.8% |
| 200-day average | $37.15 | +13.2% |
Price Risk
Over 3 years, its largest fall from a peak was 68.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.12 |
| Largest fall, 1 year | -25.0% |
| Largest fall, 3 years | -68.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About EWTX
What is EWTX's 1-year price change?
Edgewise Therapeutics's price rose 84.8% over the past 12 months. With dividends included, the 12-month total return was 84.8%.
What is EWTX's 5-year price change?
Edgewise Therapeutics's month-end price rose 135.8% over the 5 years through Oct 2026, a compound annual rate of 18.7%. These figures leave out dividends.
What is EWTX's 52-week high and low?
Edgewise Therapeutics's 52-week high is $48.78 and its 52-week low is $19.76. Its latest price of $42.04 on Nov 17, 2026 is 13.8% below the high.
What is EWTX's beta?
Edgewise Therapeutics's 1-year beta against the S&P 500 is 1.12, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 25.0%.
Is the EWTX chart free?
Yes. Advanced Charting for EWTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
EWTX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors